Back to SilverArc Capital Management, LLC

SilverArc Capital Management, LLC

All holdings · as of Dec 31, 2025

64 positions

CompanyClassValueShares% of portfolio
Kymera Therapeutics, Inc.$2.69M34,5890.4%
NextCure, Inc.NXTCCommon Stock$2.50M176,0570.4%
ELUTIA INC.ELUTCommon Stock$1.91M2,751,3140.3%
Sionna Therapeutics, Inc.$1.71M41,4600.2%
CytomX Therapeutics, Inc.$1.64M385,9740.2%
X4 Pharmaceuticals, Inc$1.43M357,3870.2%
Edgewise Therapeutics, Inc.$1.04M42,0520.2%
RADIOPHARM THERANOSTICS LIMITEDRADXADR$978.3K187,4060.1%
4D MOLECULAR THERAPEUTICS, INC.$750.0K100,0000.1%
Adagio Medical Holdings, Inc.$536.0K515,3840.1%
Rapport Therapeutics, Inc.RAPPCommon Stock$293.1K9,6590.0%
PALISADE BIO, INC.$240.0K102,1080.0%
iBio, Inc.IBIOCommon Stock$204.6K106,0000.0%
ROCKET PHARMACEUTICALS INC$2.5K104,8280.0%
← PrevPage 2 of 2Next →